452 related articles for article (PubMed ID: 28754778)
1. Cancer risk and survival in
Møller P; Seppälä TT; Bernstein I; Holinski-Feder E; Sala P; Gareth Evans D; Lindblom A; Macrae F; Blanco I; Sijmons RH; Jeffries J; Vasen HFA; Burn J; Nakken S; Hovig E; Rødland EA; Tharmaratnam K; de Vos Tot Nederveen Cappel WH; Hill J; Wijnen JT; Jenkins MA; Green K; Lalloo F; Sunde L; Mints M; Bertario L; Pineda M; Navarro M; Morak M; Renkonen-Sinisalo L; Valentin MD; Frayling IM; Plazzer JP; Pylvanainen K; Genuardi M; Mecklin JP; Moeslein G; Sampson JR; Capella G;
Gut; 2018 Jul; 67(7):1306-1316. PubMed ID: 28754778
[TBL] [Abstract][Full Text] [Related]
2. Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database.
Møller P; Seppälä T; Bernstein I; Holinski-Feder E; Sala P; Evans DG; Lindblom A; Macrae F; Blanco I; Sijmons R; Jeffries J; Vasen H; Burn J; Nakken S; Hovig E; Rødland EA; Tharmaratnam K; de Vos Tot Nederveen Cappel WH; Hill J; Wijnen J; Jenkins M; Green K; Lalloo F; Sunde L; Mints M; Bertario L; Pineda M; Navarro M; Morak M; Renkonen-Sinisalo L; Frayling IM; Plazzer JP; Pylvanainen K; Genuardi M; Mecklin JP; Möslein G; Sampson JR; Capella G;
Gut; 2017 Sep; 66(9):1657-1664. PubMed ID: 27261338
[TBL] [Abstract][Full Text] [Related]
3. Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database.
Dominguez-Valentin M; Haupt S; Seppälä TT; Sampson JR; Sunde L; Bernstein I; Jenkins MA; Engel C; Aretz S; Nielsen M; Capella G; Balaguer F; Evans DG; Burn J; Holinski-Feder E; Bertario L; Bonanni B; Lindblom A; Levi Z; Macrae F; Winship I; Plazzer JP; Sijmons R; Laghi L; Della Valle A; Heinimann K; Dębniak T; Fruscio R; Lopez-Koestner F; Alvarez-Valenzuela K; Katz LH; Laish I; Vainer E; Vaccaro C; Carraro DM; Monahan K; Half E; Stakelum A; Winter D; Kennelly R; Gluck N; Sheth H; Abu-Freha N; Greenblatt M; Rossi BM; Bohorquez M; Cavestro GM; Lino-Silva LS; Horisberger K; Tibiletti MG; Nascimento ID; Thomas H; Rossi NT; Apolinário da Silva L; Zaránd A; Ruiz-Bañobre J; Heuveline V; Mecklin JP; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Peltomäki P; Therkildsen C; Madsen MG; Burgdorf SK; Hopper JL; Win AK; Haile RW; Lindor N; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo J; Buchanan DD; Thibodeau SN; von Knebel Doeberitz M; Loeffler M; Rahner N; Schröck E; Steinke-Lange V; Schmiegel W; Vangala D; Perne C; Hüneburg R; Redler S; Büttner R; Weitz J; Pineda M; Duenas N; Vidal JB; Moreira L; Sánchez A; Hovig E; Nakken S; Green K; Lalloo F; Hill J; Crosbie E; Mints M; Goldberg Y; Tjandra D; Ten Broeke SW; Kariv R; Rosner G; Advani SH; Thomas L; Shah P; Shah M; Neffa F; Esperon P; Pavicic W; Torrezan GT; Bassaneze T; Martin CA; Moslein G; Moller P
EClinicalMedicine; 2023 Apr; 58():101909. PubMed ID: 37181409
[TBL] [Abstract][Full Text] [Related]
4. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
Møller P; Seppälä T; Bernstein I; Holinski-Feder E; Sala P; Evans DG; Lindblom A; Macrae F; Blanco I; Sijmons R; Jeffries J; Vasen H; Burn J; Nakken S; Hovig E; Rødland EA; Tharmaratnam K; de Vos Tot Nederveen Cappel WH; Hill J; Wijnen J; Green K; Lalloo F; Sunde L; Mints M; Bertario L; Pineda M; Navarro M; Morak M; Renkonen-Sinisalo L; Frayling IM; Plazzer JP; Pylvanainen K; Sampson JR; Capella G; Mecklin JP; Möslein G;
Gut; 2017 Mar; 66(3):464-472. PubMed ID: 26657901
[TBL] [Abstract][Full Text] [Related]
5. Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28].
See WA
Urol Oncol; 2013 Jul; 31(5):716. PubMed ID: 23796201
[TBL] [Abstract][Full Text] [Related]
6. Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.
Seppälä TT; Dominguez-Valentin M; Crosbie EJ; Engel C; Aretz S; Macrae F; Winship I; Capella G; Thomas H; Hovig E; Nielsen M; Sijmons RH; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Mints M; Gluck N; Katz L; Heinimann K; Vaccaro CA; Green K; Lalloo F; Hill J; Schmiegel W; Vangala D; Perne C; Strauß HG; Tecklenburg J; Holinski-Feder E; Steinke-Lange V; Mecklin JP; Plazzer JP; Pineda M; Navarro M; Vida JB; Kariv R; Rosner G; Piñero TA; Pavicic W; Kalfayan P; Ten Broeke SW; Jenkins MA; Sunde L; Bernstein I; Burn J; Greenblatt M; de Vos Tot Nederveen Cappel WH; Della Valle A; Lopez-Koestner F; Alvarez K; Büttner R; Görgens H; Morak M; Holzapfel S; Hüneburg R; von Knebel Doeberitz M; Loeffler M; Redler S; Weitz J; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Hopper JL; Win AK; Lindor NM; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo JC; Thibodeau SN; Therkildsen C; Wadt KAW; Mourits MJE; Ketabi Z; Denton OG; Rødland EA; Vasen H; Neffa F; Esperon P; Tjandra D; Möslein G; Rokkones E; Sampson JR; Evans DG; Møller P
Eur J Cancer; 2021 May; 148():124-133. PubMed ID: 33743481
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.
Seppälä TT; Ahadova A; Dominguez-Valentin M; Macrae F; Evans DG; Therkildsen C; Sampson J; Scott R; Burn J; Möslein G; Bernstein I; Holinski-Feder E; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Lautrup CK; Lindblom A; Plazzer JP; Winship I; Tjandra D; Katz LH; Aretz S; Hüneburg R; Holzapfel S; Heinimann K; Valle AD; Neffa F; Gluck N; de Vos Tot Nederveen Cappel WH; Vasen H; Morak M; Steinke-Lange V; Engel C; Rahner N; Schmiegel W; Vangala D; Thomas H; Green K; Lalloo F; Crosbie EJ; Hill J; Capella G; Pineda M; Navarro M; Blanco I; Ten Broeke S; Nielsen M; Ljungmann K; Nakken S; Lindor N; Frayling I; Hovig E; Sunde L; Kloor M; Mecklin JP; Kalager M; Møller P
Hered Cancer Clin Pract; 2019; 17():8. PubMed ID: 30858900
[TBL] [Abstract][Full Text] [Related]
8. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium.
Møller P; Seppälä T; Dowty JG; Haupt S; Dominguez-Valentin M; Sunde L; Bernstein I; Engel C; Aretz S; Nielsen M; Capella G; Evans DG; Burn J; Holinski-Feder E; Bertario L; Bonanni B; Lindblom A; Levi Z; Macrae F; Winship I; Plazzer JP; Sijmons R; Laghi L; Valle AD; Heinimann K; Half E; Lopez-Koestner F; Alvarez-Valenzuela K; Scott RJ; Katz L; Laish I; Vainer E; Vaccaro CA; Carraro DM; Gluck N; Abu-Freha N; Stakelum A; Kennelly R; Winter D; Rossi BM; Greenblatt M; Bohorquez M; Sheth H; Tibiletti MG; Lino-Silva LS; Horisberger K; Portenkirchner C; Nascimento I; Rossi NT; da Silva LA; Thomas H; Zaránd A; Mecklin JP; Pylvänäinen K; Renkonen-Sinisalo L; Lepisto A; Peltomäki P; Therkildsen C; Lindberg LJ; Thorlacius-Ussing O; von Knebel Doeberitz M; Loeffler M; Rahner N; Steinke-Lange V; Schmiegel W; Vangala D; Perne C; Hüneburg R; de Vargas AF; Latchford A; Gerdes AM; Backman AS; Guillén-Ponce C; Snyder C; Lautrup CK; Amor D; Palmero E; Stoffel E; Duijkers F; Hall MJ; Hampel H; Williams H; Okkels H; Lubiński J; Reece J; Ngeow J; Guillem JG; Arnold J; Wadt K; Monahan K; Senter L; Rasmussen LJ; van Hest LP; Ricciardiello L; Kohonen-Corish MRJ; Ligtenberg MJL; Southey M; Aronson M; Zahary MN; Samadder NJ; Poplawski N; Hoogerbrugge N; Morrison PJ; James P; Lee G; Chen-Shtoyerman R; Ankathil R; Pai R; Ward R; Parry S; Dębniak T; John T; van Overeem Hansen T; Caldés T; Yamaguchi T; Barca-Tierno V; Garre P; Cavestro GM; Weitz J; Redler S; Büttner R; Heuveline V; Hopper JL; Win AK; Lindor N; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo J; Buchanan DD; Thibodeau SN; Ten Broeke SW; Hovig E; Nakken S; Pineda M; Dueñas N; Brunet J; Green K; Lalloo F; Newton K; Crosbie EJ; Mints M; Tjandra D; Neffa F; Esperon P; Kariv R; Rosner G; Pavicic WH; Kalfayan P; Torrezan GT; Bassaneze T; Martin C; Moslein G; Ahadova A; Kloor M; Sampson JR; Jenkins MA;
Hered Cancer Clin Pract; 2022 Oct; 20(1):36. PubMed ID: 36182917
[TBL] [Abstract][Full Text] [Related]
10. No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in
Dominguez-Valentin M; Plazzer JP; Sampson JR; Engel C; Aretz S; Jenkins MA; Sunde L; Bernstein I; Capella G; Balaguer F; Macrae F; Winship IM; Thomas H; Evans DG; Burn J; Greenblatt M; de Vos Tot Nederveen Cappel WH; Sijmons RH; Nielsen M; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Lindblom A; Valle AD; Lopez-Kostner F; Alvarez K; Gluck N; Katz L; Heinimann K; Vaccaro CA; Nakken S; Hovig E; Green K; Lalloo F; Hill J; Vasen HFA; Perne C; Büttner R; Görgens H; Holinski-Feder E; Morak M; Holzapfel S; Hüneburg R; von Knebel Doeberitz M; Loeffler M; Rahner N; Weitz J; Steinke-Lange V; Schmiegel W; Vangala D; Crosbie EJ; Pineda M; Navarro M; Brunet J; Moreira L; Sánchez A; Serra-Burriel M; Mints M; Kariv R; Rosner G; Piñero TA; Pavicic WH; Kalfayan P; Broeke SWT; Mecklin JP; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Peltomäki P; Hopper JL; Win AK; Buchanan DD; Lindor NM; Gallinger S; Marchand LL; Newcomb PA; Figueiredo JC; Thibodeau SN; Therkildsen C; Hansen TVO; Lindberg L; Rødland EA; Neffa F; Esperon P; Tjandra D; Möslein G; Seppälä TT; Møller P
J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34203177
[TBL] [Abstract][Full Text] [Related]
11. Risks of less common cancers in proven mutation carriers with lynch syndrome.
Engel C; Loeffler M; Steinke V; Rahner N; Holinski-Feder E; Dietmaier W; Schackert HK; Goergens H; von Knebel Doeberitz M; Goecke TO; Schmiegel W; Buettner R; Moeslein G; Letteboer TG; Gómez García E; Hes FJ; Hoogerbrugge N; Menko FH; van Os TA; Sijmons RH; Wagner A; Kluijt I; Propping P; Vasen HF
J Clin Oncol; 2012 Dec; 30(35):4409-15. PubMed ID: 23091106
[TBL] [Abstract][Full Text] [Related]
12. Systematic immunohistochemical screening for Lynch syndrome in colorectal cancer: a single centre experience of 486 patients.
Zumstein V; Vinzens F; Zettl A; Heinimann K; Koeberle D; von Flüe M; Bolli M
Swiss Med Wkly; 2016; 146():w14315. PubMed ID: 27152634
[TBL] [Abstract][Full Text] [Related]
13. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT
J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610
[TBL] [Abstract][Full Text] [Related]
14. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.
Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP
Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743
[TBL] [Abstract][Full Text] [Related]
15. Lynch Syndrome/Hereditary Non-polyposis Colorectal Cancer (HNPCC).
Stoffel EM
Minerva Gastroenterol Dietol; 2010 Mar; 56(1):45-53. PubMed ID: 20190724
[TBL] [Abstract][Full Text] [Related]
16. Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families.
Long Q; Peng Y; Tang Z; Wu C
Int J Clin Exp Pathol; 2014; 7(10):7297-303. PubMed ID: 25400828
[TBL] [Abstract][Full Text] [Related]
17. Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study.
Eikenboom EL; Moen S; van Leerdam ME; Papageorgiou G; Doukas M; Tanis PJ; Dekker E; Wagner A; Spaander MCW;
Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1106-1117. PubMed ID: 37865103
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology of Lynch syndrome.
Cerretelli G; Ager A; Arends MJ; Frayling IM
J Pathol; 2020 Apr; 250(5):518-531. PubMed ID: 32141610
[TBL] [Abstract][Full Text] [Related]
19. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
20. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
